Lazar V, Diez S G, Laurent A, Giovangrandi Y, Radvanyi F, Chopin D, Bidart J M, Bellet D, Vidaud M
Laboratoire d'Immunologie des Tumeurs, URA 1484 CNRS, Faculté des Sciences Pharmaceutiques et Biologiques de Paris, France.
Cancer Res. 1995 Sep 1;55(17):3735-8.
Increased serum levels of human chorionic gonadotropin beta subunit (hCG beta) were described previously in patients with bladder cancer. To obtain insight into such production of hCG beta, the expression of hCG beta 7, 8, 5, and 3 genes in bladder carcinomas and normal urothelia was investigated by reverse transcription PCR. Surprisingly, hCG beta mRNAs were detected in both normal urothelial and carcinomatous cells. However, tumor progression was characterized by different patterns of transcription of the hCG beta genes; the beta 7 gene was the only gene transcribed in normal urothelia and Ta tumors included in this study, whereas in addition to beta 7, genes beta 5, 8, and 3 were transcribed in T1 to T4 tumors. Moreover, transcription levels of the latter three genes increased with the stage of the disease. These observations showed that dramatic modifications in the expression of hCG beta genes accompany progression of bladder carcinomas.
先前已有报道称膀胱癌患者血清中人绒毛膜促性腺激素β亚基(hCGβ)水平升高。为深入了解hCGβ的这种产生情况,通过逆转录聚合酶链反应研究了hCGβ7、8、5和3基因在膀胱癌组织和正常尿路上皮中的表达。令人惊讶的是,在正常尿路上皮细胞和癌细胞中均检测到了hCGβ信使核糖核酸。然而,肿瘤进展的特征是hCGβ基因的转录模式不同;β7基因是本研究中正常尿路上皮和Ta期肿瘤中唯一转录的基因,而在T1至T4期肿瘤中,除了β7基因外,β5、8和3基因也会转录。此外,后三个基因的转录水平随疾病分期而增加。这些观察结果表明,hCGβ基因表达的显著改变伴随着膀胱癌的进展。